Document:

EX-10.32

 EXHIBIT 10.32 

Agreement 
 by and between

  

	1.	Pieris AG, whose principal place of business is at Lise-Meitner-Str. 30, 85354 Freising, Germany, represented by its member of the management board Stephen Yoder 

- hereinafter referred to as the “the Company” - 

and 
  

	2.	OrbiMed Private Investments III, LP, 601 Lexington Avenue, 54th Floor, New York, NY 10022, USA 

 -
hereinafter referred to as “Lender 1” - 
  

	3.	OrbiMed Associates III, LP, 601 Lexington Avenue, 54th Floor, New York, NY 10022, USA 

- hereinafter referred to as “Lender 2” - 
  

	4.	Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, Denmark 

 - hereinafter referred to as
“Lender 3” - 
  

	5.	TransConnect Unternehmensberatungs- und Beteiligungs AG, Prinzregentenstraße 56, 80538 Munich, Germany 

- hereinafter referred to as “Lender 4” - 
  

	6.	BioM Aktiengesellschaft Munich BioTech Development, Am Klopferspitz 19 a, 82152 Planegg-Martinsried, Germany 

- hereinafter referred to as “Lender 5” - 
  

	7.	The Global Life Science Ventures Fonds II GmbH & Co. KG, Von-der-Tann-Straße 3, 80539 Munich, Germany 

- hereinafter referred to as “Lender 6” - 
  

	8.	The Global Life Science Ventures Fund II Limited Partnership, PO Box 431, Alexan-der House,13-15 Victoria Road, St. Peter Port, Guernsey, G41 3ZD 

- hereinafter referred to as “Lender 7” - 

	9.	Gilde Europe Food & Agribusiness Fund B.V., Newtonlaan 91, 3584 BP Utrecht, The Netherlands 

- hereinafter referred to as “Lender 8” - 
  

	10.	BayTech Venture Capital GmbH & Co. KG, Herzog-Heinrich-Straße 22, D-80336 Munich, Germany 

- hereinafter referred to as “Lender 9” - 
  

	11.	Coöperatieve AAC LS U.A., Gooimeer 2-35, P.O. Box 5187, 1410 AD Naarden, The Netherlands 

 -
hereinafter referred to as “Lender 10” - 
 The parties named under 2. to 11. above are hereinafter also collectively referred to as the
“Lenders” and each individually as a “Lender”. The parties named under 1. to 11. above are hereinafter also collectively referred to as the “Parties” and each individually as a
“Party”. 
 Preamble 
  

	A.	On November 12, 2012, as amended in March 2014, and on April 14, 2014, the Company and its shareholders entered into agreements regarding convertible bridge loans (Wandeldarlehen) (jointly the
“Loan Agreements”) totaling to a loan amount of EUR 4,000,000.00 (the “Loans”). 

  

	B.	The Lenders have provided to the Company loan facilities under the Loans, which are currently outstanding as follows: 

  

													
	 Lender
	  	Loan Amount
2012 (EUR)	 	  	Loan Amount
2014 (EUR)	 	  	Total
(EUR)	 
	 OrbiMed Private Investments III, LP
	  	 	492.113	  	  	 	797.987	  	  	 	1.290.100 (“Loan 1”)	 
	 OrbiMed Associates III, LP
	  	 	4.687	  	  	 	5.001	  	  	 	9.688 (“Loan 2”)	  
	 Novo Nordisk A/S
	  	 	199.606	  	  	 	199.606	  	  	 	399.212 (“Loan 3”)	  
	 TransConnect Unternehmensbera-tungs- und Beteiligungs AG
	  	 	50.285	  	  	 	53.659	  	  	 	103.944 (“Loan 4”)	  
	 BioM Aktiengesellschaft Munich Bio-Tech Development
	  	 	164.751	  	  	 	13.747	  	  	 	178.498 (“Loan 5”)	  
	 The Global Life Science Ventures Fonds II GmbH & Co. KG
	  	 	252.173	  	  	 	168.746	  	  	 	420.919 (“Loan 6”)	  
	 The Global Life Science Ventures Fund II LP
	  	 	196.145	  	  	 	131.254	  	  	 	327.399 (“Loan 7”)	  
	 Gilde Europe Food & Agribusiness Fund B.V.
	  	 	421.015	  	  	 	300.000	  	  	 	721.015 (“Loan 8”)	  
	 BayTech Venture Capital GmbH & Co. KG
	  	 	0	  	  	 	200.000	  	  	 	200.000 (“Loan 9”)	  
	 Coöperatieve AAC LS U.A.
	  	 	219.225	  	  	 	130.000	  	  	 	349.225 (“Loan 10”)	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total
	  	 	2.000.000	  	  	 	2.000.000	  	  	 	4.000.000	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

	C.	On October 10, 2014 the Parties and the other shareholders of the Company together with further investors have entered into an investment agreement (“Investment Agreement”). Pursuant to Sec. 3
para. 1 lit. f. of the Investment Agreement each of the Lenders undertook vis-à-vis each of the shareholders of the Company, but not vis-à-vis the Company, to assign to the Company its claim for repayment of the outstanding loan
facilities as stated in the table under lit. B. above and any and all interest accrued thereon and to waive vis-à-vis the Company any and all claims out of or in connection with the Loan Agreements and the corresponding Loans.

 NOW, THEREFORE, the Parties hereby agree as follows. 

§1 
 Non-Statutory
Contributions into the Capital Reserves 
  

	1.	Each of the Lenders hereby renders further contributions into the capital reserves of the Company pursuant to § 272 para. 2 No. 4 German Commercial Code (sonstige Leistungen in die Kapitalrücklage der
Gesellschaft gemäß § 272 Abs. 2 Nr. 4 HGB) by way of an assignment to the Company of the full outstanding principal amount of the Loans paid by him to the Company and any and all interest accrued thereon, in each case under the
condition that they are credited to the capital reserves of the Company within the meaning of § 272 para. 2 No. 4 HGB. The Company hereby accepts each of such assignments. 

 

	2.	A portion of the further contributions by the Lenders set forth in the below table into the capital reserves of the Company pursuant to para. 1 above shall be rendered by such Lenders on behalf of and to the benefit of
OrbiMed Private Investments III, LP (“OrbiMed LP”) as set forth in the following table: 

  

					
	 Lender
	  	Contribution on behalf
of and to the benefit of
OrbiMed LP (EUR)	 
	 Novo Nordisk A/S
	  	 	103,296	  
	 BioM Aktiengesellschaft Munich BioTech Development
	  	 	55,625	  
	 The Global Life Science Ventures Fonds II GmbH & Co. KG
	  	 	114,060	  
	 The Global Life Science Ventures Fund II LP
	  	 	88,717	  
	 Gilde Europe Food & Agribusiness Fund B.V.
	  	 	194,028	  
	 Coöperatieve AAC LS U.A.
	  	 	95,866	  
		  	  
	  
	 
	 Total
	  	 	651,592	  
		  	  
	  
	 

 §2 

Settlement of the Loan Agreements 
 Each of
the Lenders hereby waives vis-à-vis the Company any and all further rights and claims the respective Lender might have out of or in connection with the Loan Agreements and the corresponding Loans. The Company hereby accepts each of such
waivers. Each of the Lenders on the one hand and the Company on the other hand hereby agree that following the assignment under § 1 above, any and all rights and claims under the Loan Agreements are finally settled. 

§3 
 Final
Provisions 
  

	1.	Any joint and several liability (gesamtschuldnerische Haftung) of the Lenders shall be excluded. 

  

	2.	Amendments and additions to this Agreement must be made in writing to be effect-tive. This shall also apply to a waiver of the written form requirement as well as to a waiver of any right or claim under this Agreement.

  

	3.	Should individual terms of this Agreement be or become invalid or unenforceable or if this Agreement contains gaps, this shall not affect the validity of the remaining terms of this Agreement. In place of the invalid,
unenforceable or missing term, such valid term which the Parties would reasonably have agreed, had they been aware at the conclusion of this Agreement that the relevant term was invalid, unenforceable or missing, shall be deemed to have been agreed.
Should a term of this Agreement be or become invalid because of the scope or time of performance for which it provides, then the agreed scope or time of performance shall be amended to correspond with the extent legally permitted. 

 

	4.	To the extent that such an agreement is legally valid, the courts competent for Munich, Germany shall have exclusive jurisdiction over this Agreement. 

[Signature page follows] 

					
			
	 /s/ i.V. Th. Straßner
	 		 	 /s/ i.V. Th. Straßner

	 Pieris AG 

(represented by the management board)
	 		 	BioM Aktiengesellschaft Munich BioTech Development
			
	 /s/ i.V. Th. Straßner
	 		 	 /s/ i.V. Th. Straßner

	TransConnect Unternehmensberatungs- Und Beteiligungs AG	 		 	The Global Life Science Ventures Fonds II GmbH & Co. KG
			
	 /s/ i.V. Th. Straßner
	 		 	 /s/ i.V. Th. Straßner

	The Global Life Science Ventures Fund II Limited Partnership	 		 	Gilde Europe Food & Agribusiness Fund B.V.
			
	 /s/ i.V. Th. Straßner
	 		 	 /s/ i.V. Th. Straßner

	BayTech Venture Capital Gmb & Co. KG	 		 	Coöperatieve AAC LS U.A.
			
	 /s/ i.V. Th. Straßner
	 		 	 /s/ i.V. Th. Straßner

	 OrbiMed Private Investments III, LP
	 		 	OrbiMed Associates III, LP
			
	 /s/ i.V. Th. Straßner
	 		 	
	Novo Nordisk A/SEX-10.33

 EXHIBIT 10.33 

SPLIT-OFF AGREEMENT 

This SPLIT-OFF AGREEMENT, dated as of December 17, 2014 (this “Agreement”), is entered into by and among Pieris
Pharmaceuticals, Inc. (f/k/a Marika Inc.), a Nevada corporation (“Seller”), Marika Enterprises Inc., a Nevada corporation and wholly owned subsidiary of Seller (“Split-Off Subsidiary”), and Aleksandrs Sviks
(“Buyer”). 
 R E C I T A L S: 

WHEREAS, Seller is the owner of all of the issued and outstanding capital stock of Split-Off Subsidiary; Split-Off Subsidiary is a
wholly owned subsidiary of Seller which will acquire the business assets and liabilities previously held by Seller; and Seller has no other businesses or operations prior to the Acquisition (as defined herein); and 

WHEREAS, contemporaneously with the execution of this Agreement, Seller and Pieris AG, a German stock corporation
(“PrivateCo”) will enter into the Acquisition Agreement by and among the Seller, PrivateCo and the equity holders of PrivateCo, pursuant to which the equity holders of PrivateCo will receive securities of Seller in exchange for all of
their equity interests in PrivateCo (the “Acquisition”); and 
 WHEREAS, the execution and delivery of this Agreement is
required by PrivateCo as a condition to its execution of the Acquisition Agreement, and the consummation of the assignment, assumption, purchase and sale transactions contemplated by this Agreement is also a condition to the completion of the
Acquisition pursuant to the Acquisition Agreement, and Seller has represented to PrivateCo in the Acquisition Agreement that the transactions contemplated by this Agreement will be consummated contemporaneously with the closing of the Acquisition,
and PrivateCo relied on such representation in entering into the Acquisition Agreement; and 
 WHEREAS, Buyer desires to purchase the
Shares (as defined in Section 2.1) from Seller, and to assume, as between Seller and Buyer, all responsibility for any debts, obligations and liabilities of Seller (prior to the Acquisition) and Split-Off Subsidiary, on the terms and
subject to the conditions specified in this Agreement; and 
 WHEREAS, Seller desires to sell and transfer the Shares to
Buyer, on the terms and subject to the conditions specified in this Agreement; and 
 NOW, THEREFORE, in consideration of the
premises and the covenants, promises and agreements herein set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending legally to be bound, agree as follows:

 I. ASSIGNMENT AND ASSUMPTION OF SELLER’S ASSETS AND LIABILITIES. 

SUBJECT TO THE TERMS AND CONDITIONS PROVIDED BELOW: 

1.1 Assignment of Assets. Seller hereby contributes, assigns, conveys and transfers to Split-Off Subsidiary, and Split-Off
Subsidiary hereby receives, acquires and accepts, all assets 

 
and properties of Seller as of the Closing Date (as defined below) existing immediately prior to the Effective Time, including but not limited to the following, but excluding in all cases
(i) the right, title and assets of Seller in, to and under the Acquisition Agreement and the Contemplated Transactions, and (ii) the capital stock of PrivateCo and Split-Off Subsidiary: 

(a) all cash and cash equivalents; 

(b) all accounts receivable; 

(c) all inventories of raw materials, work in process, parts, supplies and finished products; 

(d) all right, title and interest, of record, beneficial or otherwise, in and to and stock, membership interests, partnership
interests or other equity or ownership interests in any corporation, limited liability company, partnership or other entity, and all bonds, debentures, notes or other securities; 

(e) all of Seller’s rights, title and interests in, to and under all contracts, agreements, leases, licenses (including
software licenses), supply agreements, consulting agreements, commitments, purchase orders, customer orders and work orders, and including all of Seller’s rights thereunder to use and possess equipment provided by third parties, and all
representations, warranties, covenants and guarantees related to the foregoing (provided that to the extent any of the foregoing or any claim or right or benefit arising thereunder or resulting therefrom is not assignable by its terms, or the
assignment thereof shall require the consent or approval of another party thereto, this Agreement shall not constitute an assignment thereof if an attempted assignment would be in violation of the terms thereof or if such consent is not obtained
prior to the Effective Time, and in lieu thereof Seller shall reasonably cooperate with Split-Off Subsidiary in any reasonable arrangement designed to provide Split-Off Subsidiary the benefits thereunder or any claim or right arising thereunder);

 (f) all intellectual property, including but not limited to issued patents, patent applications (whether or not patents
are issued thereon and whether modified, withdrawn or resubmitted), unpatented inventions, product designs, copyrights (whether registered or unregistered), know-how, technology, trade secrets, technical information, notebooks, drawings, software,
computer coding (both object and source) and all documentation, manuals and drawings related thereto, trademarks or service marks and applications therefor, unregistered trademarks or service marks, trade names, logos and icons and all rights to sue
or recover for the infringement or misappropriation thereof; 
 (g) all fixed assets, including but not limited to the
machinery, equipment, furniture, vehicles, office equipment and other tangible personal property owned or leased by Seller; 

(h) all customer lists, business records, customer records and files, customer financial records, and all other files and
information related to customers, all customer proposals, all open service agreements with customers and all uncompleted customer contracts and agreements; 

  
 2 

 (i) to the extent legally assignable, all licenses, permits, certificates,
approvals and authorizations issued by Governmental Bodies and necessary to own, lease or operate the assets and properties of Seller and to conduct Seller’s business as it is presently conducted; and 

(i) all real property or interests therein. 

ALL OF THE FOREGOING BEING REFERRED TO HEREIN AS THE “ASSIGNED ASSETS.” 

1.2 Assignment and Assumption of Liabilities. Seller hereby assigns to Split-Off Subsidiary, and Split-Off Subsidiary hereby
assumes and agrees to pay, honor and discharge all debts, adverse claims, liabilities, judgments and obligations, including tax obligations, of Seller existing as of the Closing Date immediately prior to the Effective Time, whether accrued,
contingent or otherwise and whether known or unknown, including those arising under any law (including the common law) or any rule or regulation of any Governmental Body or imposed by any court or any arbitrator in a binding arbitration resulting
from, arising out of or relating to the assets, activities, financings, offerings, operations, actions or omissions of Seller, or products manufactured or sold thereby or services provided thereby, or under contracts, agreements (whether written or
oral), leases, commitments or undertakings thereof, but excluding in all cases the obligations of Seller under the Acquisition Agreement and in connection with the Contemplated Transactions (all of the foregoing being referred to herein as
the “Assigned Liabilities”). 
 The assignment and assumption of Seller’s assets and liabilities provided for in this
Article I is referred to as the “Assignment.” 
 II. PURCHASE AND SALE OF STOCK. 

2.1 Purchased Shares. Subject to the terms and conditions provided below, Seller shall sell and transfer to Buyer and
Buyer shall purchase from Seller, on the Closing Date (as defined in Section 3.1), all of the issued and outstanding shares of capital stock of Split-Off Subsidiary (the “Shares”), as set forth in Exhibit A attached hereto.

 2.2 Purchase Price. The purchase price (the “Purchase Price”) for the Shares shall consist of the
transfer and delivery by Buyer to Seller of the type and number of shares of common stock and other securities of Seller that Buyer owns (the “Purchase Price Securities”), as set forth in Exhibit A attached hereto, deliverable as provided
in Section 3.3.  
 III. CLOSING. 

3.1 Closing. The closing of the transactions contemplated in this Agreement (the “Closing”) shall take place
simultaneously with the closing of the Acquisition immediately prior to the Effective Time. The date on which the Closing occurs shall be referred to herein as the “Closing Date.” 

3.2 Transfer of Shares. At the Closing, Seller shall deliver to Buyer certificates representing the Shares purchased by
Buyer, duly endorsed to Buyer or as directed by Buyer, which delivery shall vest Buyer with good and marketable title to such Shares, free and clear of all liens, encumbrances and adverse claims or interests. 

  
 3 

 3.3 Payment of Purchase Price. At the Closing, Buyer shall deliver to Seller
a certificate or certificates representing Buyer’s Purchase Price Securities duly endorsed to Seller, together with a Notarized Stock Power for offshore Buyer and the Waiver of Medallion Guaranty, which delivery shall vest Seller with good and
marketable title to the Purchase Price Securities, free and clear of all liens, encumbrances and adverse claims or interests. 

3.4 Transfer of Records. On or before the Closing, Seller shall transfer to Split-Off Subsidiary all existing corporate
books and records in Seller’s possession relating to Split-Off Subsidiary and its business, including but not limited to all agreements, litigation files, real estate files, personnel files and filings with governmental agencies;
provided, however, when any such documents relate to both Seller and Split-Off Subsidiary, only copies of such documents need be furnished. On or before the Closing, Buyer and Split-Off Subsidiary shall transfer to Seller all existing
corporate books and records in the possession of Buyer or Split-Off Subsidiary relating to Seller, including but not limited to all corporate minute books, stock ledgers, certificates and corporate seals of Seller and all agreements, litigation
files, real property files, personnel files and filings with governmental agencies; provided, however, when any such documents relate to both Seller and Split-Off Subsidiary or its business, only copies of such documents need be
furnished. 
 3.5 Instruments of Assignment. At the Closing, Seller and Split-Off Subsidiary shall deliver to
each other such instruments providing for the Assignment and deliver to PrivateCo executed copies of this Agreement and a general release agreement, and all other documents anticipated by such agreements and the transactions contemplated thereby and
hereby as outlined in the Acquisition Agreement as the other may reasonably request (the “Instruments of Assignment”). 
 IV.
BUYER’S REPRESENTATIONS AND WARRANTIES. BUYER REPRESENTS AND WARRANTS TO SELLER AND SPLIT-OFF SUBSIDIARY THAT: 
 4.1
Capacity and Enforceability. Buyer has the legal capacity to execute and deliver this Agreement and the documents to be executed and delivered by Buyer at the Closing pursuant to the transactions contemplated hereby. This Agreement and
all such documents constitute valid and binding agreements of Buyer, enforceable in accordance with their terms. 
 4.2
Compliance. Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby by Buyer will result in the breach of any term or provision of, or constitute a default under, or violate any
agreement, indenture, instrument, order, law or regulation to which Buyer is a party or by which Buyer is bound. 
 4.3
Purchase for Investment. Buyer is financially able to bear the economic risks of acquiring the Shares and the other transactions contemplated hereby, and has no need for liquidity in his investment in the Shares. Buyer has such
knowledge and experience in financial and business matters in general, and with respect to businesses of a nature similar to the business of Split-Off Subsidiary (after giving effect to the Assignment), so as to be capable of evaluating

  
 4 

 
the merits and risks of, and making an informed business decision with regard to, the acquisition of the Shares and the other transactions contemplated hereby. Buyer is acquiring the Shares
solely for his own account and not with a view to or for resale in connection with any distribution or public offering thereof, within the meaning of any applicable securities laws and regulations, unless such distribution or offering is registered
under the Securities Act of 1933, as amended (the “Securities Act”), or an exemption from such registration is available. Buyer has (i) received all the information he has deemed necessary to make an informed decision with respect to
the acquisition of the Shares and the other transactions contemplated hereby; (ii) had an opportunity to make such investigation as he has desired pertaining to Split-Off Subsidiary (after giving effect to the Assignment) and the acquisition of
an interest therein and the other transactions contemplated hereby, and to verify the information which is, and has been, made available to him; and (iii) had the opportunity to ask questions of Seller concerning Split-Off Subsidiary (after
giving effect to the Assignment). Buyer acknowledges that he is a current or former director and/or officer of Seller, and a current director and/or officer of Split-Off Subsidiary and, as such, has actual knowledge of the business, operations and
financial affairs of Split-Off Subsidiary (after giving effect to the Assignment). Buyer has received no public solicitation or advertisement with respect to the offer or sale of the Shares. Buyer realizes that the Shares are “restricted
securities” as that term is defined in Rule 144 promulgated by the Securities and Exchange Commission under the Securities Act, the resale of the Shares is restricted by federal and state securities laws and, accordingly, the Shares must be
held indefinitely unless their resale is subsequently registered under the Securities Act or an exemption from such registration is available for their resale. Buyer understands that any resale of the Shares by him must be registered under the
Securities Act (and any applicable state securities law) or be effected in circumstances that, in the opinion of counsel for Split-Off Subsidiary at the time, create an exemption or otherwise do not require registration under the Securities Act (or
applicable state securities laws). Buyer acknowledges and consents that certificates now or hereafter issued for the Shares will bear a legend substantially as follows: 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR QUALIFIED UNDER ANY APPLICABLE STATE SECURITIES LAWS (THE “STATE ACTS”), HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO A REGISTRATION STATEMENT UNDER
THE SECURITIES ACT AND QUALIFICATION UNDER THE STATE ACTS OR PURSUANT TO EXEMPTIONS FROM SUCH REGISTRATION OR QUALIFICATION REQUIREMENTS (INCLUDING, IN THE CASE OF THE SECURITIES ACT, THE EXEMPTIONS AFFORDED BY SECTION 4(1) OF THE SECURITIES ACT AND
RULE 144 THEREUNDER). AS A PRECONDITION TO ANY SUCH TRANSFER, THE ISSUER OF THESE SECURITIES SHALL BE FURNISHED WITH AN OPINION OF COUNSEL OPINING AS TO THE AVAILABILITY OF EXEMPTIONS FROM SUCH REGISTRATION AND QUALIFICATION AND/OR SUCH OTHER
EVIDENCE AS MAY BE SATISFACTORY THERETO THAT ANY SUCH TRANSFER WILL NOT VIOLATE THE SECURITIES LAWS. 

  
 5 

 Buyer understands that the Shares are being sold to him pursuant to the exemption from
registration contained in Section 4(1) of the Securities Act and that Seller is relying upon the representations made herein as one of the bases for claiming the Section 4(1) exemption. 

4.4 Liabilities. Following the Closing, Seller will have no liability for any debts, liabilities or obligations of
Split-Off Subsidiary or its business or activities, or the business or activities of Seller prior to the Closing that are unrelated to the business of PrivateCo, and there are no outstanding guaranties, performance or payment bonds, letters of
credit or other contingent contractual obligations that have been undertaken by Seller directly or indirectly in relation to Split-Off Subsidiary or its business, or the business of Seller prior to the Closing that are unrelated to the business of
PrivateCo, and that may survive the Closing.  
 4.5 Title to Purchase Price Securities. Buyer is the sole
record and beneficial owner of the Purchase Price Securities. At Closing, Buyer shall have good and marketable title to the Purchase Price Securities, which Purchase Price Securities are, and at the Closing will be, free and clear of all options,
warrants, pledges, claims, interests, liens and encumbrances, and any restrictions or limitations prohibiting or restricting transfer to Seller, except for restrictions on transfer as contemplated by applicable securities laws.  

V. SELLER’S AND SPLIT-OFF SUBSIDIARY’S REPRESENTATIONS AND WARRANTIES. EACH OF SELLER AND SPLIT-OFF SUBSIDIARY
REPRESENT AND WARRANT TO BUYER THAT:  
 5.1 Organization and Good Standing. Each of Seller and Split-Off
Subsidiary is a corporation duly incorporated, validly existing, and in good standing under the laws of Nevada. 
 5.2
Authority and Enforceability. The execution and delivery of this Agreement and the documents to be executed and delivered at the Closing pursuant to the transactions contemplated hereby, and performance in accordance with the terms
hereof and thereof, have been duly authorized by Seller and Split-Off Subsidiary and all such documents constitute valid and binding agreements of Seller and Split-Off Subsidiary enforceable in accordance with their terms. 

5.3 Title to Shares. Seller is the sole record and beneficial owner of the Shares. At Closing, Seller shall have good and
marketable title to the Shares, which Shares are, and at the Closing will be, free and clear of all options, warrants, pledges, claims, interests, liens and encumbrances, and any restrictions or limitations prohibiting or restricting transfer to
Buyer, except for restrictions on transfer as contemplated by Section 4.3 above. The Shares constitute all of the issued and outstanding shares of capital stock of Split-Off Subsidiary. 

5.4 WARN Act. Split-Off Subsidiary does not have a sufficient number of employees to make it subject to the Worker
Adjustment and Retraining Notification Act.  
 5.5 Representations in Acquisition Agreement. Split-Off
Subsidiary represents and warrants that all of the representations and warranties by Seller, insofar as they relate to Split-Off Subsidiary, contained in the Acquisition Agreement are true and correct. 

  
 6 

 VI. OBLIGATIONS OF BUYER PENDING CLOSING. BUYER COVENANTS AND AGREES THAT BETWEEN
THE DATE HEREOF AND THE CLOSING: 
 6.1 Not Impair Performance. Buyer shall not take any intentional action
that would cause the conditions upon the obligations of the parties hereto to effect the transactions contemplated hereby not to be fulfilled, including, without limitation, taking or causing to be taken any action that would cause the
representations and warranties made by any party herein not to be true, correct and accurate as of the Closing, or in any way impairing the ability of Seller to satisfy its obligations as provided in Article VII. 

6.2 Assist Performance. Buyer shall exercise his reasonable best efforts to cause to be fulfilled those conditions
precedent to Seller’s obligations to consummate the transactions contemplated hereby which are dependent upon actions of Buyer and to make and/or obtain any necessary filings and consents in order to consummate the transactions contemplated by
this Agreement. 
 VII. OBLIGATIONS OF SELLER AND SPLIT-OFF SUBSIDIARY PENDING CLOSING. SELLER AND SPLIT-OFF
SUBSIDIARY COVENANT AND AGREE THAT BETWEEN THE DATE HEREOF AND THE CLOSING: 
 7.1 Business as Usual.
Split-Off Subsidiary shall operate and Seller shall cause Split-Off Subsidiary to operate in accordance with past practices and shall use best efforts to preserve its goodwill and the goodwill of its employees, customers and others having business
dealings with Split-Off Subsidiary. Without limiting the generality of the foregoing, from the date of this Agreement until the Closing Date, Split-Off Subsidiary shall (a) make all normal and customary repairs to its equipment, assets and
facilities, (b) keep in force all insurance, (c) preserve in full force and effect all material franchises, licenses, contracts and real property interests and comply in all material respects with all laws and regulations, (d) collect
all accounts receivable and pay all trade creditors in the ordinary course of business at intervals historically experienced, and (e) preserve and maintain Split-Off Subsidiary’s assets in their current operating condition and repair,
ordinary wear and tear excepted. From the date of this Agreement until the Closing Date, Split-Off Subsidiary shall not (i) amend, terminate or surrender any material franchise, license, contract or real property interest, or (ii) sell or
dispose of any of its assets except in the ordinary course of business.  
 7.2 Not Impair Performance. Seller
shall not take any intentional action that would cause the conditions upon the obligations of the parties hereto to effect the transactions contemplated hereby not to be fulfilled, including, without limitation, taking or causing to be taken any
action which would cause the representations and warranties made by any party herein not to be materially true, correct and accurate as of the Closing, or in any way impairing the ability of Buyer to satisfy his obligations as provided in Article
VI. 
 7.3 Assist Performance. Seller shall exercise its reasonable best efforts to cause to be fulfilled
those conditions precedent to Buyer’s obligations to consummate the transactions contemplated hereby which are dependent upon the actions of Seller and to work with Buyer to make and/or obtain any necessary filings and consents. Seller shall
cause Split-Off Subsidiary to comply with its obligations under this Agreement. 

  
 7 

 VIII. SELLER’S AND SPLIT-OFF SUBSIDIARY’S CONDITIONS PRECEDENT TO CLOSING. THE
OBLIGATIONS OF SELLER AND SPLIT-OFF SUBSIDIARY TO CLOSE THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT ARE SUBJECT TO THE SATISFACTION AT OR PRIOR TO THE CLOSING OF EACH OF THE FOLLOWING CONDITIONS PRECEDENT (ANY OR ALL OF WHICH MAY BE WAIVED BY
SELLER AND PRIVATECO IN WRITING): 
 8.1 Representations and Warranties; Performance. All representations and
warranties of Buyer contained in this Agreement shall have been true and correct, in all material respects, when made and shall be true and correct, in all material respects, at and as of the Closing, with the same effect as though such
representations and warranties were made at and as of the Closing. Buyer shall have performed and complied with all covenants and agreements and satisfied all conditions, in all material respects, required by this Agreement to be performed or
complied with or satisfied by Buyer at or prior to the Closing. 
 8.2 Additional Documents. Buyer shall deliver
or cause to be delivered such additional documents as may be necessary in connection with the consummation of the transactions contemplated by this Agreement and the performance of their obligations hereunder. 

8.3 Release by Split-Off Subsidiary. At the Closing, Split-Off Subsidiary shall execute and deliver to Seller a general
release agreement which in substance and effect releases Seller and PrivateCo from any and all liabilities and obligations that Seller and PrivateCo may owe to Split-Off Subsidiary in any capacity, and from any and all claims that Split-Off
Subsidiary may have against Seller, PrivateCo or their respective managers, members, officers, directors, stockholders, employees and agents (other than those arising pursuant to this Agreement or any document delivered in connection with this
Agreement). 
 IX. BUYER’S CONDITIONS PRECEDENT TO CLOSING. THE OBLIGATION OF BUYER TO CLOSE THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT IS SUBJECT TO THE SATISFACTION AT OR PRIOR TO THE CLOSING OF EACH OF THE FOLLOWING CONDITIONS PRECEDENT (ANY AND ALL OF WHICH MAY BE WAIVED BY BUYER IN WRITING): 

9.1 Representations and Warranties; Performance. All representations and warranties of Seller and Split-Off Subsidiary
contained in this Agreement shall have been true and correct, in all material respects, when made and shall be true and correct, in all material respects, at and as of the Closing with the same effect as though such representations and warranties
were made at and as of the Closing. Seller and Split-Off Subsidiary shall have performed and complied with all covenants and agreements and satisfied all conditions, in all material respects, required by this Agreement to be performed or complied
with or satisfied by them at or prior to the Closing. 
 X. OTHER AGREEMENTS. 

10.1 Expenses. Each party hereto shall bear its expenses separately incurred in connection with this Agreement and with
the performance of its obligations hereunder.  

  
 8 

 10.2 Confidentiality. Buyer shall not make any public announcements
concerning this transaction without the prior written agreement of PrivateCo, other than as may be required by applicable law or judicial process. If for any reason the transactions contemplated hereby are not consummated, then Buyer shall return
any information received by Buyer from Seller, Split-Off Subsidiary or PrivateCo, and Buyer shall cause all confidential information obtained by Buyer concerning Seller, Split-Off Subsidiary, PrivateCo and each of their businesses to be treated as
such. 
 10.3 Brokers’ Fees. In connection with the transaction specifically contemplated by this
Agreement, no party to this Agreement has employed the services of a broker and each agrees to indemnify the other against all claims of any third parties for fees and commissions of any brokers claiming a fee or commission related to the
transactions contemplated hereby. 
 10.4 Access to Information Post-Closing; Cooperation. 

(a) Following the Closing, Buyer and Split-Off Subsidiary shall afford to Seller and its authorized accountants, counsel and
other designated representatives, reasonable access (and including using reasonable efforts to give access to persons or firms possessing information) and duplicating rights during normal business hours to allow records, books, contracts,
instruments, computer data and other data and information (collectively, “Information”) within the possession or control of Buyer or Split-Off Subsidiary insofar as such access is reasonably required by Seller. Information may be requested
under this Section 10.4(a) for, without limitation, audit, accounting, claims, litigation and tax purposes, as well as for purposes of fulfilling disclosure and reporting obligations and performing this Agreement and the transactions
contemplated hereby. No files, books or records of Split-Off Subsidiary existing at the Closing Date shall be destroyed by Buyer or Split-Off Subsidiary after Closing but prior to the expiration of any period during which such files, books or
records are required to be maintained and preserved by applicable law without giving Seller at least 30 days’ prior written notice, during which time Seller shall have the right to examine and to remove any such files, books and records prior
to their destruction. 
 (b) Following the Closing, Seller shall afford to Split-Off Subsidiary and its authorized
accountants, counsel and other designated representatives reasonable access (including using reasonable efforts to give access to persons or firms possessing information) and duplicating rights during normal business hours to Information within
Seller’s possession or control relating to the business of Split-Off Subsidiary insofar as such access is reasonably requested by Buyer. Information may be requested under this Section 10.4(b) for, without limitation, audit,
accounting, claims, litigation and tax purposes as well as for purposes of fulfilling disclosure and reporting obligations and for performing this Agreement and the transactions contemplated hereby. No files, books or records of Split-Off Subsidiary
existing at the Closing Date shall be destroyed by Seller after Closing but prior to the expiration of any period during which such files, books or records are required to be maintained and preserved by applicable law without giving Buyer at least
30 days’ prior written notice, during which time Buyer shall have the right to examine and to remove any such files, books and records prior to their destruction. 

  
 9 

 (c) At all times following the Closing, Seller, Buyer and Split-Off Subsidiary
shall use their reasonable efforts to make available to the other parties on written request, the current and former officers, directors, employees and agents of Seller or Split-Off Subsidiary for any of the purposes set forth in
Section 10.4(a) or (b) above or as witnesses to the extent that such persons may reasonably be required in connection with any legal, administrative or other proceedings in which Seller or Split-Off Subsidiary may from time to be
involved. 
 (d) The party to whom any Information or witnesses are provided under this Section 10.4 shall
reimburse the provider thereof for all out-of-pocket expenses actually and reasonably incurred in providing such Information or witnesses. 

(e) Seller, Buyer, Split-Off Subsidiary and their respective employees and agents shall each hold in strict confidence all
Information concerning the other party in their possession or furnished by the other or the other’s representative pursuant to this Agreement with the same degree of care as such party utilizes as to such party’s own confidential
information (except to the extent that such Information is (i) in the public domain through no fault of such party or (ii) later lawfully acquired from any other source by such party), and each party shall not release or disclose such
Information to any other person, except such party’s auditors, attorneys, financial advisors, bankers, other consultants and advisors or persons to whom such party has a valid obligation to disclose such Information, unless compelled to
disclose such Information by judicial or administrative process or, as advised by its counsel, by other requirements of law. 

(f) Seller, Buyer and Split-Off Subsidiary shall each use their reasonable best efforts to forward promptly to the other party
all notices, claims, correspondence and other materials which are received and determined to pertain to the other party. 
 10.5
Guarantees, Surety Bonds and Letter of Credit Obligations. In the event that Seller is obligated for any debts, obligations or liabilities of Split-Off Subsidiary by virtue of any outstanding guarantee, performance or surety bond or
letter of credit provided or arranged by Seller on or prior to the Closing Date, Buyer and Split-Off Subsidiary shall use their best efforts to cause to be issued replacements of such bonds, letters of credit and guarantees and to obtain any
amendments, novations, releases and approvals necessary to release and discharge fully Seller from any liability thereunder following the Closing. Buyer and Split-Off Subsidiary, jointly and severally, shall be responsible for, and shall indemnify,
hold harmless and defend Seller from and against, any costs or losses incurred by Seller arising from such bonds, letters of credit and guarantees and any liabilities arising therefrom and shall reimburse Seller for any payments that Seller may be
required to pay pursuant to enforcement of its obligations relating to such bonds, letters of credit and guarantees. 
 10.6
Filings and Consents. Buyer, at his risk, shall determine what, if any, filings and consents must be made and/or obtained prior to Closing to consummate the purchase and sale of the Shares. Buyer shall indemnify the Seller Indemnified
Parties (as defined in Section 12.1 below) against any Losses (as defined in Section 12.1 below) incurred by such Seller Indemnified Parties by virtue of the failure to make and/or obtain any such filings or consents.
Recognizing that the failure to make and/or obtain any filings or consents may cause Seller to 

  
 10 

 
incur Losses or otherwise adversely affect Seller, Buyer and Split-Off Subsidiary confirm that the provisions of this Section 10.6 will not limit Seller’s right to treat such
failure as the failure of a condition precedent to Seller’s obligation to close pursuant to Article VIII above. 

10.7 Insurance. Buyer acknowledges that on the Closing Date, effective as of the Closing, any insurance coverage and
bonds provided by Seller for the Buyer or for Split-Off Subsidiary, and all certificates of insurance evidencing that Buyer or Split-Off Subsidiary maintain any required insurance by virtue of insurance provided by Seller, will terminate with
respect to any insured damages resulting from matters occurring subsequent to Closing.  
 10.8 Agreements Regarding
Taxes. 
 (a) Tax Sharing Agreements. Any tax sharing agreement between Seller and Split-Off Subsidiary
is terminated as of the Closing Date and will have no further effect for any taxable year (whether the current year, a future year or a past year). 

(b) Returns for Periods Through the Closing Date. Seller will include the income and loss of Split-Off Subsidiary
(including any deferred income triggered into income by Reg. §1.1502-13 and any excess loss accounts taken into income under Reg. §1.1502-19) on Seller’s consolidated federal income tax returns for all periods through the Closing Date
and pay any federal income taxes attributable to such income. Seller and Split-Off Subsidiary agree to allocate income, gain, loss, deductions and credits between the period up to Closing (the “Pre-Closing Period”) and the period after
Closing (the “Post-Closing Period”) based on a closing of the books of Split-Off Subsidiary, and both Seller and Split-Off Subsidiary agree not to make an election under Reg. §1.1502-76(b)(2)(ii) to ratably allocate the year’s
items of income, gain, loss, deduction and credit. Seller, Split-Off Subsidiary and Buyer agree to report all transactions not in the ordinary course of business occurring on the Closing Date after Buyer’s purchase of the Shares on Split-Off
Subsidiary’s tax returns to the extent permitted by Reg. §1.1502-76(b)(1)(ii)(B). Buyer agrees to indemnify Seller for any additional tax owed by Seller (including tax owed by Seller due to this indemnification payment) resulting from any
transaction engaged in by Split-Off Subsidiary or Seller (not related to the Acquisition) during the Pre-Closing Period or on the Closing Date before Buyer’s purchase of the Shares. Split-Off Subsidiary will furnish tax information to Seller
for inclusion in Seller’s consolidated federal income tax return for the period which includes the Closing Date in accordance with Split-Off Subsidiary’s past custom and practice. 

(c) Audits. Seller will allow Split-Off Subsidiary and its counsel to participate at Split-Off Subsidiary’s
expense in any audit of Seller’s consolidated federal income tax returns to the extent that such audit raises issues that relate to and increase the tax liability of Split-Off Subsidiary. Seller shall have the absolute right, in its sole
discretion, to engage professionals and direct the representation of Seller in connection with any such audit and the resolution thereof, without receiving the consent of Buyer or Split-Off Subsidiary or any other party acting on behalf of Buyer or
Split-Off Subsidiary, provided that Seller will not settle any such audit in a manner which would materially adversely affect Split-Off Subsidiary after the Closing Date unless such settlement would be reasonable in the case of a person that owned
Split-Off Subsidiary 

  
 11 

 
both before and after the Closing Date, or unless the Split-Off Subsidiary provides written consent, such consent not to be unreasonably withheld. In the event that after Closing any tax
authority informs Buyer or Split-Off Subsidiary of any notice of proposed audit, claim, assessment or other dispute concerning an amount of taxes which pertain to Seller, or to Split-Off Subsidiary during the period prior to Closing, Buyer or
Split-Off Subsidiary must promptly notify Seller of the same within 15 calendar days of the date of the notice from the tax authority. In the event Buyer or Split-Off Subsidiary does not notify Seller within such 15 day period, Buyer and Split-Off
Subsidiary, jointly and severally, will indemnify Seller for any incremental interest, penalty or other assessments resulting from the delay in giving notice. To the extent of any conflict or inconsistency, the provisions of this Section 10.8
shall control over the provisions of Section 12.2 below. 
 (d) Cooperation on Tax Matters. Buyer, Seller
and Split-Off Subsidiary shall cooperate fully, as and to the extent reasonably requested by any party, in connection with the filing of tax returns pursuant to this Section and any audit, litigation or other proceeding with respect to taxes. Such
cooperation shall include the retention and (upon the other party’s request) the provision of records and information which are reasonably relevant to any such audit, litigation or other proceeding and making employees available on a mutually
convenient basis to provide additional information and explanation of any material provided hereunder. Split-Off Subsidiary shall (i) retain all books and records with respect to tax matters pertinent to Split-Off Subsidiary and Seller relating
to any taxable period beginning before the Closing Date until the expiration of the statute of limitations (and, to the extent notified by Seller, any extensions thereof) of the respective taxable periods, and abide by all record retention
agreements entered into with any taxing authority, and (ii) give Seller reasonable written notice prior to transferring, destroying or discarding any such books and records and, if Seller so requests, Buyer agrees to cause Split-Off Subsidiary
to allow Seller to take possession of such books and records. 
 10.9 ERISA. Effective as of the Closing Date,
Split-Off Subsidiary shall terminate its participation in, and withdraw from, any employee benefit plans sponsored by Seller, and Seller and Buyer shall cooperate fully in such termination and withdrawal. Without limitation, Split-Off Subsidiary
shall be solely responsible for (i) all liabilities under those employee benefit plans notwithstanding any status as an employee benefit plan sponsored by Seller, and (ii) all liabilities for the payment of vacation pay, severance
benefits, and similar obligations, including, without limitation, amounts which are accrued but unpaid as of the Closing Date with respect thereto. Buyer and Split-Off Subsidiary acknowledge and agree that Split-Off Subsidiary is solely responsible
for providing continuation health coverage, as required under the Consolidated Omnibus Reconciliation Act of 1985, as amended (“COBRA”), to each person, if any, participating in an employee benefit plan subject to COBRA with respect to
such employee benefit plan as of the Closing Date, including, without limitation, any person whose employment with Split-Off Subsidiary is terminated after the Closing Date. 

  
 12 

 XI. TERMINATION. THIS AGREEMENT MAY BE TERMINATED AT, OR AT ANY TIME PRIOR TO, THE
CLOSING BY MUTUAL WRITTEN CONSENT OF SELLER, BUYER AND PRIVATECO. 
 If this Agreement is terminated as provided herein, it shall
become wholly void and of no further force and effect and there shall be no further liability or obligation on the part of any party except to pay such expenses as are required of such party. 

XII. INDEMNIFICATION. 

12.1 Indemnification by Buyer and Split-Off Subsidiary. Each of Buyer and Split-Off Subsidiary, jointly and severally, covenant
and agree to indemnify, defend, protect and hold harmless Seller and PrivateCo, and their respective officers, directors, employees, stockholders, agents, representatives and Affiliates (collectively, the “Seller Indemnified Parties”) at
all times from and after the date of this Agreement from and against all losses, liabilities, damages, claims, actions, suits, proceedings, demands, assessments, adjustments, costs and expenses (including specifically, but without limitation,
reasonable attorneys’ fees and expenses of investigation), whether or not involving a third party claim and regardless of any negligence of any Seller Indemnified Party (collectively, “Losses”), incurred by any Seller Indemnified
Party as a result of or arising from (i) any breach of the representations and warranties of Buyer set forth herein or in certificates delivered in connection herewith, (ii) any breach or nonfulfillment of any covenant or agreement
(including any other agreement of Buyer to indemnify set forth in this Agreement) on the part of Buyer under this Agreement, (iii) any Assigned Asset or Assigned Liability or any other debt, liability or obligation of Split-Off Subsidiary,
(iv) the conduct and operations, (A) prior to Closing, of the business of Seller unrelated to the assets that are the subject of the Acquisition, (B) whether before or after Closing, of (X) the business of Seller pertaining to
the Assigned Assets and Assigned Liabilities or (Y) the business of Split-Off Subsidiary, (v) claims asserted (including claims for payment of taxes), whether before or after Closing, (A) against Split-Off Subsidiary or
(B) pertaining to the Assigned Assets and Assigned Liabilities or to the business of Seller prior to the Closing, or (vi) any federal or state income tax payable by Seller or PrivateCo and attributable to the transactions contemplated by
this Agreement or to the business of Seller prior to the Closing. For the purposes of this Agreement, an “Affiliate” is a person or entity that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is
under common control with, another specified person or entity. 

  
 13 

 12.2 Third Party Claims. If any claim or liability (a “Third-Party
Claim”) should be asserted against any of the Seller Indemnified Parties (the “Indemnitee”) by a third party after the Closing for which Buyer has an indemnification obligation under the terms of Section 12.1, then the
Indemnitee shall notify Buyer (the “Indemnitor”) within 20 days after the Third-Party Claim is asserted by a third party (said notification being referred to as a “Claim Notice”). The expenses (including reasonable
attorneys’ fees) of all negotiations, proceedings, contests, lawsuits or settlements with respect to any Third-Party Claim shall be borne by the Indemnitor. The Indemnitor shall not be entitled to assume the defense of any Third-Party Claim.
The Indemnitor shall be responsible for paying all settlements made or judgments entered with respect to any Third-Party Claim. A failure by the Indemnitee to timely give the Claim Notice shall not excuse Indemnitor from any indemnification
liability except only to the extent that the Indemnitor is materially and adversely prejudiced by such failure. 
 12.3
Non-Third-Party Claims. Upon discovery of any claim for which Buyer has an indemnification obligation under the terms of Section 12.1 which does not involve a claim by a third party against the Indemnitee, the Indemnitee
shall give prompt notice to Buyer of such claim and, in any case, shall give Buyer such notice within 30 days of such discovery. A failure by Indemnitee to timely give the foregoing notice to Buyer shall not excuse Buyer from any indemnification
liability except to the extent that Buyer is materially and adversely prejudiced by such failure. 
 12.4 Survival.
Except as otherwise provided in this Section 12.4, all representations and warranties made by Buyer, Split-Off Subsidiary and Seller in connection with this Agreement shall survive the Closing. Anything in this Agreement to the contrary
notwithstanding, the liability of the Indemnitor under this Article XII shall terminate on the third (3rd) anniversary of the Closing Date, except with respect to (a) liability
for any item as to which, prior to the third (3rd) anniversary of the Closing Date, any Indemnitee shall have asserted a claim in writing, which claim shall identify its basis with reasonable
specificity, in which case the liability for such claim shall continue until it shall have been finally settled, decided or adjudicated, (b) liability of any party for Losses for which such party has an indemnification obligation, incurred as a
result of such party’s breach of any covenant or agreement to be performed by such party after the Closing, (c) liability of Buyer for Losses incurred by a Seller Indemnified Party due to breaches of its representations and warranties in
Article IV of this Agreement, and (d) liability of Buyer for Losses arising out of Third-Party Claims for which Buyer has an indemnification obligation, which liability shall survive until the statute of limitation applicable to any
third party’s right to assert a Third-Party Claim bars assertion of such claim. 
 XIII. MISCELLANEOUS. 

13.1 Definitions. Capitalized terms used herein without definition have the meanings ascribed to them in the Acquisition
Agreement. 

  
 14 

 13.2 Notices. All notices and communications required or permitted hereunder
shall be in writing and deemed given when received by means of the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, or personal delivery, or overnight courier, as
follows: 
  

	 	(a)	If to Seller, addressed to: 

 Pieris Pharmaceuticals, Inc. 

2360 Corporate Circle, Suite 400 

Henderson, NV 89074 
 Attn:
Aleksandrs Sviks 
 Tel: 702-425-4332 

With a copy to (which shall not constitute notice hereunder): 

Crone Kline Rinde LLP 
 488
Madison Avenue, 12th Fl. 
 New York, NY 10022 

Attn: Mark E. Crone 
 Fax:
1-212-400-6901 
  

	 	(b)	If to Buyer or Split-Off Subsidiary, addressed to: 

 Aleksandrs Sviks 

54-35 Muzjanu Street 
 Riga,
Latvia, LV-1064 
 With a copy to (which shall not constitute notice hereunder): 

Crone Kline Rinde LLP 
 488
Madison Avenue, 12th Fl. 
 New York, NY 10022 

Attn: Mark E. Crone 
 Fax:
1-212-400-6901 
  

	 	(c)	If to PrivateCo, addressed to: 

 Pieris AG 

Lise-Meitner-Straße 30 

85354 Freising, Germany 
 Attn.
Stephen S. Yoder, CEO 
 Fax: +4981611411444 

With a copy to (which shall not constitute notice hereunder): 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 

One Financial Center 
 Boston,
MA 02111 
 Attn: William Hicks 

Fax: 1-617-542-2241 

  
 15 

 or to such other address as any party hereto shall specify pursuant to this Section 13.2 from time to
time. 
 13.3 Exercise of Rights and Remedies. Except as otherwise provided herein, no delay of or omission in the
exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any
such breach or default, or of any similar breach or default occurring later; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 

13.4 Time. Time is of the essence with respect to this Agreement. 

13.5 Reformation and Severability. In case any provision of this Agreement shall be invalid, illegal or unenforceable, it
shall, to the extent possible, be modified in such manner as to be valid, legal and enforceable but so as to most nearly retain the intent of the parties, and if such modification is not possible, such provision shall be severed from this Agreement,
and in either case the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby. 

13.6 Further Acts and Assurances. From and after the Closing, Seller, Buyer and Split-Off Subsidiary agree that each will
act in a manner supporting compliance, including compliance by its Affiliates, with all of its obligations under this Agreement and, from time to time, shall, at the request of another party hereto, and without further consideration, cause the
execution and delivery of such other instruments of conveyance, transfer, assignment or assumption and take such other action or execute such other documents as such party may reasonably request in order more effectively to convey, transfer to and
vest in Buyer, and to put Split-Off Subsidiary in possession of, all Assigned Assets and Assigned Liabilities, and to convey, transfer to and vest in Seller and Buyer, and to them in possession of, the Purchase Price Securities and the Shares
(respectively), and, in the case of any contracts and rights that cannot be effectively transferred without the consent or approval of another person that is unobtainable, to use its best reasonable efforts to ensure that Split-Off Subsidiary
receives the benefits thereof to the maximum extent permissible in accordance with applicable law or other applicable restrictions, and shall perform such other acts which may be reasonably necessary to effectuate the purposes of this Agreement.

 13.7 Entire Agreement; Amendments. This Agreement contains the entire understanding of the parties relating to
the subject matter contained herein. This Agreement cannot be amended or changed except through a written instrument signed by all of the parties hereto and by PrivateCo. No provisions of this Agreement or any rights hereunder may be waived by any
party without the prior written consent of PrivateCo. 
 13.8 Assignment. No party may assign his, her or its
rights or obligations hereunder, in whole or in part, without the prior written consent of the other parties. 
 13.9
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to principles of conflicts or choice of laws thereof. 

  
 16 

 13.10 Counterparts. This Agreement may be executed in one or more
counterparts, with the same effect as if all parties had signed the same document. Each such counterpart shall be an original, but all such counterparts taken together shall constitute a single agreement. In the event that any signature is delivered
by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature page was an original
thereof. 
 13.11 Section Headings and Gender. The section headings used herein are inserted for reference
purposes only and shall not in any way affect the meaning or interpretation of this Agreement. All personal pronouns used in this Agreement shall include the other genders, whether used in the masculine, feminine or neuter, and the singular shall
include the plural, and vice versa, whenever and as often as may be appropriate. 
 13.12 Third-Party
Beneficiary. Each of Seller, Buyer and Split-Off Subsidiary acknowledges and agrees that this Agreement is entered into for the express benefit of PrivateCo, and that PrivateCo is relying hereon and on the consummation of the transactions
contemplated by this Agreement in entering into and performing its obligations under the Acquisition Agreement, and that PrivateCo shall be in all respects entitled to the benefit hereof and to enforce this Agreement as a result of any breach
hereof. 
 13.13 Specific Performance; Remedies. Each of the parties to this Agreement acknowledges and agrees
that if any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, irreparable damages would be incurred by the other parties to this Agreement and to PrivateCo. Accordingly, the parties to this
Agreement agree that any party or PrivateCo will be entitled to seek an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and its terms and provisions in any action
instituted in any court of the United States or any state thereof having jurisdiction over the parties and the matter, subject to Section 13.9, in addition to any other remedy to which they may be entitled, at law or in equity. Except as
expressly provided herein, the rights, obligations and remedies created by this Agreement are cumulative and are in addition to any other rights, obligations or remedies otherwise available at law or in equity, and nothing herein will be considered
an election of remedies.  
 13.14 Submission to Jurisdiction; Process Agent; No Jury Trial. 

(a) Each party to the Agreement hereby submits to the jurisdiction of any state or federal court sitting in the Borough of
Manhattan, City and State of New York, in any action arising out of or relating to this Agreement and agrees that all claims in respect of the action may be heard and determined in any such court. Each party to the Agreement also agrees not to bring
any action arising out of or relating to this Agreement in any other court. Each party to the Agreement agrees that a final judgment in any action so brought will be conclusive and may be enforced by action on the judgment or in any other manner
provided at law or in equity. Each party to the Agreement waives any defense of inconvenient forum to the maintenance of any action so brought and waives any bond, surety or other security that might be required of any other party with respect
thereto. 

  
 17 

 (b) EACH PARTY TO THIS AGREEMENT HEREBY AGREES TO WAIVE ITS RIGHTS TO JURY TRIAL
OF ANY DISPUTE BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OTHER AGREEMENTS RELATING TO THE SUBJECT MATTER OF THIS AGREEMENT OR ANY DEALINGS AMONG THEM RELATING TO THE TRANSACTIONS CONTEMPLATED HEREBY. The scope of this waiver is intended to
be all encompassing of any and all actions that may be filed in any court and that relate to the subject matter of the transactions, including contract claims, tort claims, breach of duty claims and all other common law and statutory claims. Each
party to the Agreement hereby acknowledges that this waiver is a material inducement to enter into a business relationship and that they will continue to rely on the waiver in their related future dealings. Each party to the Agreement further
represents and warrants that it has reviewed this waiver with its legal counsel, and that each knowingly and voluntarily waives its jury trial rights following consultation with legal counsel. NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, THIS
WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED ORALLY OR IN WRITING, AND THE WAIVER WILL APPLY TO ANY AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING HERETO. In the
event of commencement of any action, this Agreement may be filed as a written consent to trial by a court. 
 13.15
Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the
parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party because of the authorship of any provision of this Agreement. Any reference to any federal, state, local or foreign law will be deemed also to refer to
law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including” will be deemed to be followed by “without
limitation.” The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless
expressly so limited. The parties hereto intend that each representation, warranty and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty or covenant contained herein in any
respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which that party has not breached will not detract from or mitigate the fact that
such party is in breach of the first representation, warranty or covenant. 
 [Signature page follows this page.] 

  
 18 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Split-Off Agreement as of
the day and year first above written. 
  

			
	SELLER
	
	PIERIS PHARMACEUTICALS, INC.
		
	By:	 	 /s/ Aleksandrs Sviks

	Name:	 	Aleksandrs Sviks
	Title:	 	President
	
	SPLIT-OFF SUBSIDIARY
	
	MARIKA ENTERPRISES INC.
		
	By:	 	 /s/ Aleksandrs Sviks

	Name:	 	Aleksandrs Sviks
	Title:	 	President
	
	BUYER
	
	 /s/ Aleksandrs Sviks

	Aleksandrs Sviks

 EXHIBIT A 
  

							
	 BUYER
	  	PURCHASE PRICE
SECURITY	  	NUMBER	 
			
	 Aleksandrs Sviks
	  	Common Stock	  	 	5,000,000	  
			
	 Aleksandrs Sviks
	  	Common Stock (in Book Entry)	  	 	6,363,635	* 

  

	*	Shares issued as dividend shares. 

 Total number of Purchase Price Securities: 11,636,635 

Number of issued and outstanding shares of capital stock of Split-Off Subsidiary (the “Shares”): 100

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]